News
novembre 2024
-
27 November 2024The FDA to curb controversial animal testing, UK recommendation to adopt NAMs in chemical regulation, AI and genomic for phage therapy and more
NEWS, REPORTS & POSITION STATEMENTS 1. The FDA wants to curb controversial animal testing — Here’s how they plan to do it According to FDA administrator Chad P. Nelson and colleagues in a new paper, the agency is working to develop new approach […]
Read more -
20 November 2024ECHA investigates how to replace toxicity testing with fish, EU consultation on AI Act, Deep RNA sequencing to explore human neurology, and more
NEWS, REPORTS & POSITION STATEMENTS 1. QMUL leads project to revolutionise drug discovery with next-generation organ-chip technology Queen Mary University of London (QMUL) in collaboration with a consortium of leading pharmaceutical companies, organ-chip technology providers, and regulatory bodies, has secured […]
Read more -
14 November 2024Tackling AI challenges in drug discovery, How hearts-on-chips can save millions, Revolutionary high-speed 3D bioprinter and more
NEWS, REPORTS & POSITION STATEMENTS 1. VICT3R : New European project aims to reduce animal testing using AI Launched in September, the VICT3R project (Virtual Control animals 3R) will analyze historical data from pharmaceutical companies to create synthetic virtual animals using generative […]
Read more -
6 November 2024Brazilian Chemical Management Bill, Call for US Central NAMs Data Hub, Survey on Reviewer Requests for Animal Experiments in India, and more
NEWS, REPORTS & POSITION STATEMENTS 1. Brazilian Senate : A chemicals management bill to limit animal testing to a “last resort” Brazil’s Senate has approved a new chemical management bill that restricts animal testing to a “last resort” and requires development […]
Read more
